Drugs / BMS-986179
last change Oct 2021 re-read 2 minutes ago

BMS-986179

Developed for
cancer
Investigated by
Bristol-Myers Squibb

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02754141 Jun 2016 → Oct 2021 cancer Bristol-Myers Squibb Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BMS-986179 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02754141